Dr. Julie Gralow
Vice President for Healthcare Outcomes Policy and
Oncology and Molecular Radiation Sciences
University of Washington School of Medicine, Seattle, WA.
Norway
Biography
Julie R. Gralow, MD, is the Jill Bennett Endowed Professor of Breast Cancer and Director of Breast Medical Oncology at the University of Washington/Seattle Cancer Care Alliance, and a Member of the Clinical Research Division of the Fred Hutchinson Cancer Research Center. She is also a professor in the University of Washington’s Department of Global Health. She is actively involved in breast cancer clinical care, education, and research, and has served as Principal Investigator on local and national clinical trials related to breast cancer treatment, prevention, and survivorship. Her area of research specialization is the relationship between breast cancer and the bone, and she led the 6,000 patient SWOG S0307 phase III adjuvant trial of bisphosphonates in the adjacent treatment of breast cancer
Research Interest
Dr. Gralow is SWOG Executive Officer for Breast and Lung Cancer, having served 12 years as Vice-Chair of the SWOG breast cancer committee. She is currently a member of ASCO’s Cancer Education Committee in the Global Health Track, co-chair of ASCO’s Resource Stratified Guideline Advisory Group, and a member of the ASCO Breast Cancer Advisory Guideline Group. She received an ASCO Statesman Award in 2008, was elected a Fellow of the American College of Physicians in 2008, and received the Seattle Business Magazine Leaders in Healthcare Achievement in Community Outreach Award in 2014. Dr. Gralow is committed to improving the quality of life for breast cancer patients through education, exercise and diet, and to promoting breast cancer awareness in the community. She is Founder, Medical Director and Team Physician for Team Survivor Northwest, a non-profit aimed at helping female cancer survivors improve their health through fitness and exercise. Dr. Gralow is the founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN) which supports cancer advocacy and education in low- and middle-income countries,